Can Urinary Gamma Glutamyl Transferase be Used as a Bone Resorption Marker in Postmenopausal Osteoporosis?

dc.contributor.authorTikiz, C
dc.contributor.authorUlman, C
dc.contributor.authorTaneli, F
dc.contributor.authorAcar, EY
dc.contributor.authorGümüser, G
dc.contributor.authorHorasan, GD
dc.date.accessioned2025-04-10T10:29:35Z
dc.date.available2025-04-10T10:29:35Z
dc.description.abstractObjectives: To evaluate whether gamma-glutamyl transferase can be used as a new novel bone resorption marker in postmenopusal osteoporotic subjects. Design and methods: 156 postmenopausal subjects were divided into three groups according to their lumbar spine T-score measured by dual-energy X-ray absorptiometry as normal, (control group, n=56), osteopenic (n=50) and osteoporotic (n=50). Deoxypyridinoline and gamma-glutamyl transferase from urine samples and osteocalcin and bone specific alkaline phosphates from blood samples were assessed. Results: Osteocalcin and bone specific alkaline phosphates levels were increased in osteoporotic group (p<0.05). Although there is a tendency to increase in deoxypyridinoline values in osteoporotic group, this difference did not reach to a statistical significance. No significant differences were observed in urinary gamma-glutamyl transferase levels between the three groups (p>0.05). No significant correlation was found between urinary gamma-glutamyl transferase and deoxypyridinoline, bone specific alkaline phosphates and osteocalcin (p>0.05). Urinary gamma-glutamyl transferase levels showed no significant correlation with neither bone mineral density nor T scores in all subjects (r=0.058 p=0.625, r=-0.074 p=0.533 respectively). Conclusions: Our primary findings did not support the suggestion that urinary g-glutamyl transferase could be used as a potential marker for bone resorption in postmenopusal osteoporotic subjects.
dc.identifier.e-issn1303-829X
dc.identifier.issn0250-4685
dc.identifier.urihttp://hdl.handle.net/20.500.14701/36262
dc.language.isoEnglish
dc.titleCan Urinary Gamma Glutamyl Transferase be Used as a Bone Resorption Marker in Postmenopausal Osteoporosis?
dc.typeArticle

Files